Dr Gary David Newquist, PHD in Agoura Hills, CA - Psychologist

Dr Gary David Newquist, PHD is a Psychologist - Clinical based in Agoura Hills, California. Dr Gary David Newquist is licensed to practice in California (license number PSY10987) and his current practice location is 5923 Kanan Rd, Agoura Hills, California. He can be reached at his office (for appointments etc.) via phone at (805) 603-3282.

NPI number for Dr Gary David Newquist is 1669684627 and his current mailing address is Po Box 803, Newbury Park, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1669684627.

Contact Information

	Dr Gary David Newquist, PHD
	5923 Kanan Rd, Agoura Hills, CA 91301-1688
	(805) 603-3282
	Not Available

Healthcare Provider's Profile

Full Name	Dr Gary David Newquist
Gender	Male
Speciality	Psychologist - Clinical
Location	5923 Kanan Rd, Agoura Hills, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1669684627
Provider Enumeration Date: 05/04/2007
Last Update Date: 11/04/2015

Medical Identifiers

Medical identifiers for Dr Gary David Newquist such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1669684627	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
106H00000X	Marriage & Family Therapist	MFC17973 (California)	Secondary
103TC0700X	Psychologist - Clinical	PSY10987 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Gary David Newquist is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Gary David Newquist, PHD Po Box 803, Newbury Park, CA 91319-0803 Ph: (805) 603-3282	Dr Gary David Newquist, PHD 5923 Kanan Rd, Agoura Hills, CA 91301-1688 Ph: (805) 603-3282

News Archive

Maternal depression adversely affects quality of life in children with epilepsy

A study by Canadian researchers examined the prevalence of maternal depression and its impact on children newly diagnosed with epilepsy. Prevalence of depression in mothers ranged from 30%-38% within the first 24 months following a child's epilepsy diagnosis. The mother's depressive symptoms negatively impacted the child's health-related quality of life, but the effects were moderated by the amount of family resources and mediated by how well the family functions and the extent of family demands. Details of this novel study appear online in Epilepsia, a journal published by Wiley-Blackwell on behalf of the International League Against Epilepsy.

Seattle Genetics commences two SGN-CD19A phase I trials in hematologic malignancies

Seattle Genetics, Inc. today announced the initiation of two phase I clinical trials of SGN-CD19A, one for patients with B-cell acute lymphoblastic leukemia (ALL) and one for patients with B-cell non-Hodgkin lymphomas.

Study identifies world's first genetic and environmental risk factor for common childhood epilepsy

A new study of childhood epilepsy has identified the world's first environmental risk factor for the disease - maternal smoking in pregnancy, and discovered a new genetic association with the condition, pointing to potential new treatments for the disease.

Schizophrenia: A major public health problem

Schizophrenia is a major public health problem. Affecting almost 1% of the world's population, it takes an enormous economic and social toll in addition to the distress, dysfunction, disability and mortality for those afflicted with this disease. Elements of the disease are present from birth, other aspects emerge during developmental years, and the illness becomes fully expressed in early adulthood with long-lasting implications for most patients.

Study: Smartphone apps for skin cancer diagnosis are poorly regulated and unreliable

Smartphone apps used as ‘early warning systems' for skin cancer are poorly regulated and frequently cannot be relied upon to produce accurate results, according to new analysis by experts at the University of Birmingham.

Dr Gary David Newquist, PHD - Couples Therapy in Agoura Hills, CA